About DermTech
DermTech is a company based in San Diego (United States) founded in 1996 was acquired by Constellation Alpha in March 2019. DermTech has raised $24.37 million across 6 funding rounds from investors including RTW Investments, Constellation Alpha and Jacob Hanoch. The company has 259 employees as of December 31, 2022. DermTech offers products and services including DermTech Melanoma Test and Smart Stickers. DermTech operates in a competitive market with competitors including Castle Biosciences, NeuMoDx, Molbio Diagnostics, Kryptos Biotechnologies and AMLo Biosciences, among others.
- Headquarter San Diego, United States
- Employees 259 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dermtech, Llc
-
Annual Revenue
$15.3 M (USD)5as on Dec 31, 2023
-
Net Profit
-$100.89 M (USD)14as on Dec 31, 2023
-
EBITDA
-$103.74 M (USD)12as on Dec 31, 2023
-
Total Equity Funding
$24.37 M (USD)
in 6 rounds
-
Latest Funding Round
$65 M (USD), Post-IPO
Mar 13, 2020
-
Investors
RTW Investments
& 2 more
-
Employee Count
259
as on Dec 31, 2022
-
Acquired by
Constellation Alpha
(Mar 18, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DermTech
DermTech offers a comprehensive portfolio of products and services, including DermTech Melanoma Test and Smart Stickers.
Non-invasive test to detect melanoma via genomic markers.
Adhesive devices for sample collection in skin lesion analysis.
People of DermTech
Unlock access to complete
Unlock access to complete
Funding Insights of DermTech
DermTech has successfully raised a total of $24.37M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $65 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DermTech
DermTech has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include RTW Investments, Constellation Alpha and Jacob Hanoch.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in the US
|
Locked | Locked | Locked | |
|
JH
Jacob Hanoch |
-
|
Locked | Locked | Locked |
|
Venture capital firm focused on innovative healthcare companies
|
Locked | Locked | Locked |
Investor details for DermTech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DermTech
Investment portfolio details for DermTech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DermTech
Detailed financials for DermTech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dermtech Comparisons
Peer comparison for DermTech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DermTech
DermTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Castle Biosciences, NeuMoDx, Molbio Diagnostics, Kryptos Biotechnologies and AMLo Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
|
| Locked | Locked | Locked |
Prognostic tests for early-stage melanoma detection are developed.
|
Detailed competitors of DermTech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dermtech
Complete news archive for DermTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DermTech
DermTech was founded in 1996 and raised its 1st funding round 16 years after it was founded.
DermTech is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
DermTech is a funded company, having raised a total of $24.37M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at DermTech is 259.
Annual revenue of DermTech is $15.3M as on Dec 31, 2023.
DermTech was founded in 1996 in San Diego, United States. qPCR assays and diagnostic aids are developed for non-invasive analysis of skin samples to identify melanoma and other skin cancers. Cells from the outermost skin layer are captured using a proprietary adhesive patch applied directly to the patients skin. Gene expression levels in collected samples are then evaluated for diagnostic purposes in the dermatology sector.
DermTech's top competitors include Molbio Diagnostics, NeuMoDx and AMLo Biosciences.
DermTech offers DermTech Melanoma Test and Smart Stickers.
DermTech has 3 investors. Key investors include RTW Investments, Constellation Alpha, and Jacob Hanoch.